e-learning
resources
Munich 2006
Tuesday 05.09.2006
Metabolic control in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
To investigate the ubiquitin-proteasome in obstructive sleep apnea/hopynea syndrome
Z. Huang, X. Gao, Q. Ou, S. Qing, C. Ye (Guangzhou, China)
Source:
Annual Congress 2006 - Metabolic control in obstructive sleep apnoea
Session:
Metabolic control in obstructive sleep apnoea
Session type:
Oral Presentation
Number:
3373
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Huang, X. Gao, Q. Ou, S. Qing, C. Ye (Guangzhou, China). To investigate the ubiquitin-proteasome in obstructive sleep apnea/hopynea syndrome. Eur Respir J 2006; 28: Suppl. 50, 3373
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Could obstructive sleep apnea syndrome be a component of metabolic syndrome?
Source: Eur Respir J 2006; 28: Suppl. 50, 414s
Year: 2006
Frequency and importance of metabolic syndrome in obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 414s
Year: 2006
The role of inflammatory biomarkers in obstructive sleep apnea syndrome
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018
Predictors of obstructive sleep apnea syndrome and metabolic syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
The genetic and cardiovascular aspects of obstructive sleep apnoea/hypopnoea syndrome
Source: Eur Respir J 2009; 33: 233-236
Year: 2009
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
The impact of obstructive sleep apnea syndrome on cardiovascular system in children
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Investigation of various factors in obstructive sleep apnea syndrome patients
Source: Eur Respir J 2006; 28: Suppl. 50, 194s
Year: 2006
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
APAP impact on metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome?
Source: Eur Respir J 2008; 31: 1381-1382
Year: 2008
5-lipoxygenase pathway: one of the mediators of early atherosclerosis in obstructive sleep apnea syndrome?
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Metabolic syndrome in moderate to severe obstructive sleep apnea?
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
The role of obstructive sleep apnea syndrome in the metabolic syndrome – a population-based study in women
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008
The relationship between obstructive sleep apnea syndrome and two common urological disorders
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
The metabolic consequences of obstructive sleep apnoea in children
Source: Breathe 2009; 6: 111-114
Year: 2009
Endothelial dysfunction in patients with obstructive sleep apnea independent of metabolic syndrome
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Autonomic changes during obstructive and central apneas in patients with sleep apnea syndrome
Source: Eur Respir J 2001; 18: Suppl. 33, 333s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept